AKT1 and osteosarcoma: The PI3K/AKT inhibitor LY294002 was added to the osteosarcoma cell lines MG-63 and 143B with overexpression of miR-524, and we found that in response to LY294002, cell proliferation induced by miR-524 was completed reversed (Fig. 6a, b).